Karan Nagar

3.3k total citations
19 papers, 322 citations indexed

About

Karan Nagar is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Karan Nagar has authored 19 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Immunology. Recurrent topics in Karan Nagar's work include Bladder and Urothelial Cancer Treatments (7 papers), Nanoplatforms for cancer theranostics (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Karan Nagar is often cited by papers focused on Bladder and Urothelial Cancer Treatments (7 papers), Nanoplatforms for cancer theranostics (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Karan Nagar collaborates with scholars based in United States, Israel and Japan. Karan Nagar's co-authors include Timothy C. Wang, Yagnesh Tailor, Jonathan Coleman, Kwanghee Kim, Avigdor Scherz, Richard A. Friedman, Daniel L. Worthley, Bernhard W. Renz, Jan Grimm and Samuel Asfaha and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Karan Nagar

15 papers receiving 319 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karan Nagar United States 7 108 90 65 63 56 19 322
André Käding Germany 10 38 0.4× 82 0.9× 25 0.4× 128 2.0× 117 2.1× 12 375
Vasiliki Economopoulos Canada 8 41 0.4× 42 0.5× 75 1.2× 15 0.2× 57 1.0× 19 285
Liangliang Meng China 9 49 0.5× 30 0.3× 64 1.0× 12 0.2× 50 0.9× 23 361
Hsueh-Yuan Chang United States 8 45 0.4× 24 0.3× 19 0.3× 13 0.2× 54 1.0× 9 320
Lorena P. Suarez‐Kelly United States 12 44 0.4× 140 1.6× 71 1.1× 18 0.3× 111 2.0× 20 366
Ina Patties Germany 13 71 0.7× 49 0.5× 64 1.0× 7 0.1× 54 1.0× 19 312
Scott E. Forseen United States 8 20 0.2× 44 0.5× 28 0.4× 14 0.2× 81 1.4× 19 255
Peter Milos Sweden 10 43 0.4× 18 0.2× 53 0.8× 12 0.2× 30 0.5× 26 308
Mengxi Zhou China 10 55 0.5× 16 0.2× 56 0.9× 33 0.5× 39 0.7× 26 434
Tsveta S. Malinova Netherlands 7 31 0.3× 85 0.9× 26 0.4× 7 0.1× 81 1.4× 7 341

Countries citing papers authored by Karan Nagar

Since Specialization
Citations

This map shows the geographic impact of Karan Nagar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karan Nagar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karan Nagar more than expected).

Fields of papers citing papers by Karan Nagar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karan Nagar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karan Nagar. The network helps show where Karan Nagar may publish in the future.

Co-authorship network of co-authors of Karan Nagar

This figure shows the co-authorship network connecting the top 25 collaborators of Karan Nagar. A scholar is included among the top collaborators of Karan Nagar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karan Nagar. Karan Nagar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Chen, Ziyu, Karan Nagar, John R. Christin, et al.. (2024). Abstract 6006: Modeling antibody drug conjugate sensitivity using urothelial carcinoma patient-derived models. Cancer Research. 84(6_Supplement). 6006–6006. 1 indexed citations
2.
Kimura, Yasushi, Masashi Fujimori, Kwanghee Kim, et al.. (2023). Macrophage activity at the site of tumor ablation can promote murine urothelial cancer via transforming growth factor-β1. Frontiers in Immunology. 14. 1070196–1070196. 3 indexed citations
3.
Kim, Kwanghee, Sadna Budhu, Wesley Yip, et al.. (2023). Abstract 2421: WST-11 vascular-targeted photodynamic therapy induced immune modulation in upper tract urothelial cancer. Cancer Research. 83(7_Supplement). 2421–2421.
4.
Chen, Ziyu, Karan Nagar, John R. Christin, et al.. (2023). Abstract 472: HER2 as a therapeutic target in bladder cancer. Cancer Research. 83(7_Supplement). 472–472.
5.
Yip, Wesley, Daniel D. Sjoberg, Lucas Nogueira, et al.. (2022). PD58-05 FINAL RESULTS OF A PHASE I TRIAL OF WST11 (TOOKAD SOLUBLE) VASCULAR-TARGETED PHOTODYNAMIC THERAPY FOR UPPER TRACT UROTHELIAL CARCINOMA. The Journal of Urology. 207(Supplement 5).
6.
Nogueira, Lucas, Karan Nagar, Christopher Hughes, et al.. (2021). Combined OX40 Agonist and PD-1 Inhibitor Immunotherapy Improves the Efficacy of Vascular Targeted Photodynamic Therapy in a Urothelial Tumor Model. Molecules. 26(12). 3744–3744. 10 indexed citations
7.
Tracey, Andrew, Fengshen Kuo, Timothy N. Clinton, et al.. (2021). Single cell RNA sequencing of upper tract urothelial carcinoma to reveal significant heterogeneity of the tumor and immune microenvironment.. Journal of Clinical Oncology. 39(6_suppl). 484–484.
8.
Lenis, Andrew T., Timothy N. Clinton, Wenhuo Hu, et al.. (2021). Genomic characterization of bladder cancer with variant histology.. Journal of Clinical Oncology. 39(6_suppl). 470–470. 1 indexed citations
9.
Haedicke, Katja, Lilach Agemy, Murad Omar, et al.. (2020). High-resolution optoacoustic imaging of tissue responses to vascular-targeted therapies. Nature Biomedical Engineering. 4(3). 286–297. 96 indexed citations
10.
Nogueira, Lucas, Karan Nagar, Avigdor Scherz, et al.. (2020). Combined OX40 agonist and PD-1 inhibitor immunotherapy improves the efficacy of vascular targeted photodynamic therapy in a urothelial tumor model.. Journal of Clinical Oncology. 38(15_suppl). e17004–e17004. 3 indexed citations
11.
12.
Lebdai, Souhil, Mathieu Gigoux, Karan Nagar, et al.. (2019). Potentiating vascular-targeted photodynamic therapy through CSF-1R modulation of myeloid cells in a preclinical model of prostate cancer. OncoImmunology. 8(6). e1581528–e1581528. 13 indexed citations
13.
Hughes, Christopher J., Karan Nagar, Nathan C. Wong, et al.. (2019). The potential risk of tumor progression after use of dehydrated human amnion/chorion membrane allograft in a positive margin resection model. Therapeutic Advances in Urology. 11. 2078059339–2078059339. 8 indexed citations
14.
Dubeykovskaya, Zinaida A., Huan Deng, Giovanni Valenti, et al.. (2018). Therapeutic potential of adenovirus-mediated TFF2-CTP-Flag peptide for treatment of colorectal cancer. Cancer Gene Therapy. 26(1-2). 48–57. 2 indexed citations
15.
Chen, Xiaowei, Yoshihiro Takemoto, Huan Deng, et al.. (2017). Histidine decarboxylase (HDC)-expressing granulocytic myeloid cells induce and recruit Foxp3+ regulatory T cells in murine colon cancer. OncoImmunology. 6(3). e1290034–e1290034. 38 indexed citations
16.
Miller, Cassandra, Sureshkumar Muthupalani, Zeli Shen, et al.. (2016). Lamellipodin-Deficient Mice: A Model of Rectal Carcinoma. PLoS ONE. 11(4). e0152940–e0152940. 4 indexed citations
17.
Si, Yiling, Xiaowei Chen, Daniel L. Worthley, et al.. (2016). Neural innervation stimulates splenic TFF2 to arrest myeloid cell expansion and cancer. Nature Communications. 7(1). 10517–10517. 109 indexed citations
18.
Chen, Xiaowei, Michael Churchill, Karan Nagar, et al.. (2015). IL-17 producing mast cells promote the expansion of myeloid-derived suppressor cells in a mouse allergy model of colorectal cancer. Oncotarget. 6(32). 32966–32979. 28 indexed citations
19.
Renz, Bernhard W., Marina Macchini, Yoku Hayakawa, et al.. (2015). Abstract 5079: Parasympathetic signaling suppresses pancreatic cancer development. Cancer Research. 75(15_Supplement). 5079–5079. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by André Käding Breakdown of academic impact, for papers by Vasiliki Economopoulos Breakdown of academic impact, for papers by Liangliang Meng Breakdown of academic impact, for papers by Hsueh-Yuan Chang Breakdown of academic impact, for papers by Lorena P. Suarez‐Kelly Breakdown of academic impact, for papers by Ina Patties Breakdown of academic impact, for papers by Scott E. Forseen Breakdown of academic impact, for papers by Peter Milos Breakdown of academic impact, for papers by Mengxi Zhou Breakdown of academic impact, for papers by Tsveta S. Malinova
Rankless by CCL
2026